NMDA-type Glutamatergic Modulation in Dopaminergic Activation Measured by Apomorphine-Induced Cage Climbing Behaviors

Archives of Pharmacal Research

Volumn 24, Issue 6, 2001, Pages 613-617

  Jang, Choon Gon ^a   Lee, Seok Yong ^a  

^a Sungkyunkwan University   (South Korea)

Author keywords

Climbing behavior; Dopamine receptors; Glutamate receptors; NMDA receptors

Indexed keywords

6 CYANO 7 NITRO 2,3 QUINOXALINEDIONE; APOMORPHINE; DIZOCILPINE MALEATE; DOPAMINE RECEPTOR; METABOTROPIC RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR;

ANIMAL; ANIMAL BEHAVIOR; ARTICLE; DRUG EFFECT; INSTITUTE FOR CANCER RESEARCH MOUSE; MALE; MOUSE; PHYSIOLOGY;

6-CYANO-7-NITROQUINOXALINE-2,3-DIONE; ANIMALS; APOMORPHINE; BEHAVIOR, ANIMAL; DIZOCILPINE MALEATE; MALE; MICE; MICE, INBRED ICR; RECEPTORS, DOPAMINE; RECEPTORS, METABOTROPIC GLUTAMATE; RECEPTORS, N-METHYL-D-ASPARTATE;

EID: 0035751692     PISSN: 02536269     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02975175     Document Type: Article

References (24)

1. Bruton, R. K., Ge, J., and Barnes, N. M., Group I mGlu receptor modulation of dopamine release in the rat striatum in vivo. Eur. J. Pharmacol., 369, 175-181 (1999).
2. Cheramy, A., Romo, R., Godeheu, G., Baruch, P., and Glowinski, J., In vivo presynaptic controle of dopamine release in the cat caudate nucleus-II. Facilitatory or inhibitory influence of L-glutamate. Neuroscience, 19, 1081-1090 (1986).
3. Costentin, J., Protais, P., and Schwartz, J. C., Rapid and dissociated changes in sensitivities of different dopamine receptors in mouse brain. Nature, 257, 405-407 (1975)
4. Fonnum, F., Glutamate: a neurotransmitter in mammalian brain. J. Neurochem. 42, 1-10 (1984).
5. Haley, T. J. and McCormick, W. G., Pharmacological effects produced by intracerebral injection of drugs in the conscious mouse. Br. J. Pharmacol., 12, 12-15 (1957).
6. Hassler, R., Haug, P. C. Nitsch, J. S. Kim., and K. Paik. Effect of motor and premotor cortex ablation on concentrations of amino acids, monoamines, and acetylcholine and on the ultrastructure in rat striatum. A confirmation of glutamate as the specific cortico-striatal transmitter. J. Neumchem., 38:1087-1098 (1982).
7. Jones, S. M., Snell, L. D., and Johnson, K. M. Inhibition by phencyclidine of excitatory amino acid stimulated release of neurotransmitter in the nucleus accumbens. Neuropharmacology, 26, 173-179 (1987).
8. Karler, R., Calder, S. D., Chaudhry, I. A., and Turkanis, S. A., Blockade of "reverse tolerance" to cocaine and amphetamine by MK-801. Life Sci., 45, 599-606 (1989).
9. Kemp, J. M. and Powell, T. P. S., The corticostriate projection in the monkey. Brain, 93, 525-546 (1970).
10. Kim, H. S., Rhee, G. S., Jung, J. Y., Lee J. H., Jang, C. G., and Park, W. K., Inhibition by noncompetitive NMDA receptor antagonists of apomorphine-induced climbing behavior in mice. Life Sci., 58, 1397-1402 (1996).
11. Layer, R. T., Uretski, N. J., and Wallace, L. J., Effects of the AMPA/kainate receptor antagonist DNQX in the nucleus accumbens on drug-induced conditioned place preference. Brain Res., 617, 267-273 (1993).
12. 3H] dopamine from rat brain in vitro : Effects of opioids on release induced by potassium, nicotine and L-glutamic acid. Can. J. Physiol. Pharmacol., 61, 43-60 (1983).
13. McDonald, J. W. and Johnston, M. V., Physical and pathophysiological roles of excitatory amino acids during central nervous system development. Brain. Res. Rev., 15, 41-70 (1990).
14. McGeer, P. L., McGeer, E. G., Scherer, U., and Singh, K., A glutamatergic corticostriatal pathway? Brain Res. 128, 369-373 (1977).
15. Mount, H., Quirion, R., Chaudieu, I., and Boksa, P., Stimulation of dopamine release from cultured rat mesencephalic cells by naturally occurring excitatory amino acids: involvement of both N-methyl-D-aspartate (NMDA) and non-NMDA receptor subtypes. J. Neurochem., 55, 268-275 (1990).
16. Pudiak, C. M. and Bozarth, M. A., L-NAME and MK-801 attenuate sensitization to the locomotor- stimulating effect of cocaine. Life Sci., 53, 1517-1524 (1993).
17. Pulvirenti, L., Swerdlow, N. R., and Koob, G. F., Nucleus accumbens NMDA antagonist decreases locomotor activity produced by cocaine, heroin, or accumbens dopamine, but not caffeine. Pharmacol. Biochem. Behav., 40, 841-845 (1991).
18. Taylor, C. P., Geer, J. J., and Burke, S. P., Endogenous extracellular glutamate accumulation in rat neocortical cultures by reversal of the transmembrane sodium gradient. Neurosci. Lett., 145, 197-200 (1992).
19. Trujillo, A. K. and Akill, H., Inhibition of morphine tolerance and dependence by the NMDA receptor antagonist MK-801. Science, 251, 85-87 (1991).
20. Vanover, K. E., Effects of AMPA receptor antagonists on dopamine-mediated behaviors in mice. Psychopharmacology (Berl), 136, 123-131 (1998)
21. Walaas, I. and Fonnum, F., The effects of surgical and chemical lesions on neurotransmitter candidates on the nucleus accumbens. Neuroscience, 4, 209-216 (1979).
22. Webster, K. E., The corticostriatal projection in the cat. J. Anal. 99, 329-337 (1965).
23. Willins, D. L., Wallace, L. J., Miller, D. D., and Uretsky, N. J., α-Amino-3-hydroxy-5-methylisoxasole-4-proprionate/ kainite receptor antagonists in the nucleus accumbens and ventral pallidum decrease the hypermotility response to psychomotor stimulant drugs. J. Pharmacol. Exp. Ther., 260, 1145-1151 (1992).
24. Young, A. M. J. and Bradford, H. F., Excitatory amino acid neurotransmitters in the corticostriatal pathway: Studies using intracerebral microdialysis in vivo. J. Neurochem., 47, 1399-1404 (1986).